Canadian Society of Addiction Medicine Position Statement in Support of Supervised Consumption Services
Notice bibliographique
Résumé
INTRODUCTION The Canadian Society of Addiction Medicine (CSAM-SMCA) supports supervised consumption services (SCS) and recognizes their important role in addiction care. CSAM-SMCA is a national society of medical professionals and scientists committed to helping Canadians understand addiction and recover with dignity from substance use disorders. We support evidence-based practice in all 4 pillars of addiction care, including harm reduction, prevention, treatment, and enforcement. We support the implementation and continued operation of SCS across Canada as an evidence-based harm reduction strategy that saves lives, reduces the health and social consequences of substance use, and improves access to care for people who use drugs. Canada continues to face an opioid poisoning emergency. Between 2016 and 2024, over 47,000 people died of opioid overdose. Amidst this ongoing public health crisis, SCS, including overdose prevention sites, have emerged as a vital component of the national response. SCS are regulated health facilities where people are monitored by trained staff while using pre-obtained substances. Staff are available to provide education, support, resources, and emergency medical care for drug poisoning events. Sites vary across the country in terms of services offered. For example, most are not equipped for inhalation, despite shifts in drug use. Community engagement and treatment connections also vary but are important ways sites should provide further support. Even with these limitations, the benefits of SCS are supported by robust peer-reviewed research. Key benefits of SCS include: Reduction in overdose deaths: Multiple studies have shown that SCS significantly reduce overdose mortality in surrounding communities.1–3 Decreased transmission of infectious diseases: SCS reduce the spread of blood-borne infections such as HIV and hepatitis C by providing sterile equipment and safer injection education.4,5 Community benefits: SCS do not promote or increase drug use. Research shows that public drug use and crime levels remain the same or decrease in areas surrounding these services.6–8 Cost-effectiveness: Economic analyses demonstrate that SCS provide significant cost savings by preventing overdose deaths and reducing the burden on emergency services and hospitals.9–11 Improved access to care and treatment: SCS serve as a critical point of contact for marginalized individuals, facilitating entry into detoxification, treatment, and primary health care.12–15 CSAM-SMCA’s mission is to advance the understanding and treatment of substance use disorders, and to provide hope and dignity for all touched by addiction. Supervised Consumption Services are a life-saving, evidence-based component of Canada’s response to the toxic drug crisis as part of the pillar of harm reduction, and alongside prevention, treatment, and enforcement. CSAM-SMCA urges all levels of government, health care providers, and community stakeholders to support the expansion and destigmatization of these critical services.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,015 | 0,051 |
| Méta-épidémiologie (sens strict) | 0,001 | 0,001 |
| Méta-épidémiologie (sens large) | 0,002 | 0,002 |
| Bibliométrie | 0,003 | 0,004 |
| Études des sciences et des technologies | 0,012 | 0,004 |
| Communication savante | 0,010 | 0,004 |
| Science ouverte | 0,008 | 0,006 |
| Intégrité de la recherche | 0,027 | 0,021 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,083 | 0,019 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».